John Lilleyman Explained

Sir John Stuart Lilleyman (born 9 July 1945) is a British paediatric haematologist. His specialization is childhood leukemia and idiopathic thrombocytopenic purpura.[1]

Career

Lilleyman contributed to the testing of leukemia treatment methods and conducted research on "thiopurine metabolism" in children with leukemia.[1]

He was president of the Royal College of Pathologists during the Alder Hey organs scandal.[1] During that time, he was vice-chairman of the Academy of the Medical Royal Colleges.[1]

In 2004, he became medical director of the National Patient Safety Agency (NPSA).[2]

Awards and honours

In 1991, the Royal College of Pathologists awarded him its first Distinguished Service Medal for establishing the United Kingdom's system of pathology laboratory accreditation.[3] He was appointed president of the Royal Society of Medicine in 2004.[2]

Selected publications

Books

Notes and References

  1. Web site: Sir John Lilleyman . acmedsci.ac.uk . 1 July 2023 . https://web.archive.org/web/20230701104625/https://acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/fellow/Sir-John-Lilleyman-0006318 . 1 July 2023.
  2. 10.1136/bmj.332.7536.s50. Professor Sir John Lilleyman. British Medical Journal. Career Focus. 332. 7536. s50. 2006. Sanai. Leyla.
  3. Journal of Clinical Pathology. 1993. 46. 1. 1. -John Lilleyman: Editor 1986-1992. 10.1136/jcp.46.1.1 . 16811188. 501088.